Knowledge

Laminopathy

Source đź“ť

29: 482:
11 of the gene, thereby causing the deletion of the processing site on prelamin A. This results in an accumulation of progerin that is unable to mature into lamin A, leading to misshapen nuclei. Missplicing also leads to the complete or partial loss of exon 11 and results in a truncated prelamin A
1116:
The recent progress in uncovering the molecular mechanisms of toxic progerin formation in laminopathies leading to premature aging has opened up the potential for the development of targeted treatment. The farnesylation of prelamin A and its pathological form progerin is carried out by the enzyme
428:
in the lamin A/C rod and tail domains are the cause for a wide array of genetic disorders, suggesting that lamin A/C protein contains distinct functional domains that are essential for the maintenance and integrity of different cell lineages. Interaction between lamin A and the nuclear envelope
2909:
Hoffmann K, Dreger CK, Olins AL, Olins DE, Shultz LD, Lucke B, Karl H, Kaps R, Muller D, Vaya A, Aznar J, Ware RE, Cruz NS, Lindner TH, Herrmann H, Reis A, Sperling K (2002). "Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huet
449:
The most common mutation in the lamin A/C is the homozygous Arg527His (arginine replaced by histidine at position 527) substitution in exon 9 of the LMNA gene Other known mutations are Ala529Val and Arg527His/Val440Met. Additionally, some mutations such as Arg527Cys, Lys542Asn, Arg471Cys,
2832:
Caux F, Dubosclard E, Lascols O, Buendia B, Chazouilleres O, Cohen A, Courvalin JC, Laroche L, Capeau J, Vigouroux C, Christin-Maitre S (2003). "A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated
211:. Since the first reports of laminopathies in the late 1990s, increased research efforts have started to uncover the vital role of nuclear envelope proteins in cell and tissue integrity in animals. Laminopathies are a group of degenerative diseases, other disorders associated with 2604:
Bonne G, Di Barletta MR, Varnous S, Becane HM, Hammouda EH, Merlini L, Muntoni F, Greenberg CR, Gary F, Urtizberea JA, Duboc D, Fardeau M, Toniolo D, Schwartz K (1999). "Mutations in the gene encoding lamin A/C cause autosomal dominant Emery–Dreifuss muscular dystrophy".
2263:
Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, Huang JD, Li KM, Chau PY, Chen DJ, Pei D, Pendas AM, Cadiñanos J, López-Otín C, Tse HF, Hutchison C, Chen J, Cao Y, Cheah KS, Tryggvason K, Zhou Z (2005). "Genomic instability in laminopathy-based premature aging".
499:
activity cause defects similar to laminopathies caused by prelamin A with truncated processing sites. Symptoms in patients with ZMPSTE24 mutation range from mandibuloacral dysplasia, progeroid appearance, and generalized lipodystrophy to infant-lethal
2076:
Navarro CL, De Sandre-Giovannoli A, Bernard R, Boccaccio I, Boyer A, Genevieve D, Hadj-Rabia S, Gaudy-Marqueste C, Smitt HS, Vabres P, Faivre L, Verloes A, Van Essen T, Flori E, Hennekam R, Beemer FA, Laurent N, Le Merrer M, Cau P, Levy N (2004).
2441:
Charniot JC, Pascal C, Bouchier C, Sebillon P, Salama J, Duboscq-Bidot L, Peuchmaurd M, Desnos M, Artigou JY, Komajda M (2003). "Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype".
1657:
Young, Alexander Neil; Perlas, Emerald; Ruiz-Blanes, Nerea; Hierholzer, Andreas; Pomella, Nicola; Martin-Martin, Belen; Liverziani, Alessandra; Jachowicz, Joanna W.; Giannakouros, Thomas; Cerase, Andrea (2021-04-12).
366:
defects. Mutations in these genes might lead to defects in filament assembly and/or attachment to the nuclear envelope and thus jeopardize nuclear envelope stability in physically stressed tissues such as
2164:
Lassoued K, Guilly MN, Danon F, Andre C, Dhumeaux D, Clauvel JP, Brouet JC, Seligmann M, Courvalin JC (1988). "Antinuclear autoantibodies specific for lamins. Characterization and clinical significance".
440:
Most lamin B mutations appear to be lethal with mutations in lamin B1 causing death at birth in mice. In 2006, lamin B2 missense mutations were identified in patients with acquired partial lipodystrophy.
1901:
Zirn B, Kress W, Grimm T, Berthold LD, et al. (2008). "Association of homozygous LMNA mutation R471C with new phenotype: mandibuloacral dysplasia, progeria, and rigid spine muscular dystrophy".
1449:
Hoffmann, Katrin; Dreger, Christine K.; Olins, Ada L.; Olins, Donald E.; Shultz, Leonard D.; Lucke, Barbara; Karl, Hartmut; Kaps, Reinhard; Müller, Dietmar; Vayá, Amparo; Aznar, Justo (2002-07-15).
1133:, are already in use as anti-tumor medication in humans and may become avenues of treatment for children with laminopathic progeria. Nitrogen-containing bisphosphate drugs used in the treatment of 1852:
Novelli G, Muchir A, Sangiuolo F, Helbling-Leclerc A, D'Apice MR, Massart C, Capon F, Sbraccia P, Federici M, Lauro R, Tudisco C, Pallotta R, Scarano G, Dallapiccola B, Merlini L, Bonne G (2002).
564:
and are more sensitive to DNA damaging agents. The inability to adequately repair DNA damages when A-type lamins are defective is likely responsible for some of the aspects of premature aging.
2307:
Chen L, Lee L, Kudlow BA, Dos Santos HG, Sletvold O, Shafeghati Y, Botha EG, Garg E, Hanson NB, Martin GM, Mian IS, Kennedy BK, Oshima J (2003). "LMNA mutations in atypical Werner's syndrome".
255:(premature aging). Most of these symptoms develop after birth, typically during childhood or adolescence. Some laminopathies however may lead to an early death, and mutations of lamin B1 ( 417:. This allows lamin A to dissociate from the nuclear envelope membrane and fulfill nuclear functions. Mutations causing laminopathies interfere with these processes on different levels. 1504:
Waterham, Hans R.; Koster, Janet; Mooyer, Petra; Noort, Gerard van; Kelley, Richard I.; Wilcox, William R.; Ronald Wanders, J.A.; Raoul Hennekam, C.M.; Jan Oosterwijk, C. (April 2003).
1998:
Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS (2003).
433:. Different mutations lead to dominant-negative and recessive alleles. Mutations in the lamin rod domain leading to mislocalization of both lamin A and emerin occur in patients with 484: 1125:(FTIs) can be used effectively to reduce symptoms in two mouse model systems for progeria and to revert the abnormal nuclear morphology in progeroid cell cultures. Two oral FTIs, 2487:"Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot–Marie–Tooth disorder type 2) and mouse" 3760: 2793:"Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B)" 2350:
Hellemans J, Preobrazhenska O, Willaert A, Debeer P, Verdonk PCM, Costa T, Janssens K, Menten B, Van Roy N, Vermeulen SJT, Savarirayan R, Van Hul W, et al. (2004).
2953:
Captur, Gabriella; Arbustini, Eloisa; Bonne, Gisèle; Syrris, Petros; Mills, Kevin; Wahbi, Karim; Mohiddin, Saidi A.; McKenna, William J.; Pettit, Stephen (2017-11-25).
2121:
Padiath QS, Saigoh K, Schiffmann R, Asahara H, Yamada T, Koeppen A, Hogan K, Ptacek LJ, Fu YH (2006). "Lamin B1 duplications cause autosomal dominant leukodystrophy".
1392:
Padiath QS, Saigoh K, Schiffmann R, Asahara H, Yamada T, Koeppen A, Hogan K, Ptácek LJ, Fu YH (2006). "Lamin B1 duplications cause autosomal dominant leukodystrophy".
4034: 2744:"Autosomal recessive HEM/Greenberg skeletal dysplasia is caused by 3-beta-hydroxysterol delta(14)-reductase deficiency due to mutations in the lamin B receptor gene" 2214:
Redwood AB, Perkins SM, Vanderwaal RP, Feng Z, Biehl KJ, Gonzalez-Suarez I, Morgado-Palacin L, Shi W, Sage J, Roti-Roti JL, Stewart CL, Zhang J, Gonzalo S (2011).
282:(LMNB2 gene) have been linked to Barraquer-Simons syndrome and duplication in the gene coding for lamin B1 (LMNB1 gene) cause autosomal dominant leukodystrophy. 2485:
De Sandre-Giovannoli A, Chaouch M, Kozlov S, Vallat JM, Tazir M, Kassouri N, Szepetowski P, Hammadouche T, Vandenberghe A, Stewart CL, Grid D, Levy N (2002).
3996: 1506:"Autosomal Recessive HEM/Greenberg Skeletal Dysplasia Is Caused by 3β-Hydroxysterol Δ14-Reductase Deficiency Due to Mutations in the Lamin B Receptor Gene" 1167:"Dermal fibroblasts in Hutchinson–Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress" 2954: 1561:
Greenberg, Cheryl R.; Rimoin, David L.; Gruber, Helen E.; DeSa, D. J. B.; Reed, M.; Lachman, Ralph S.; Optiz, John M.; Reynolds, James F. (March 1988).
3396: 3593: 2200: 1946:"A novel homozygous p.Arg527Leu LMNA mutation in two unrelated Egyptian families causes overlapping mandibuloacral dysplasia and progeria syndrome" 1435: 1378: 2391:
Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, Atherton J, Vidaillet HJ, Spudich S, De Girolami U, Seidman JG, Seidman CE (1999).
2648:
Raffaele di Barletta M, Ricci E, Galluzzi G, Tonali P, Mora M, Morandi L, Romorini A, Voit T, Orstavik KH, Merlini L, Trevisan C, Biancalana V,
4083: 3529: 3479: 3173: 548:
promote genetic stability by maintaining the levels of proteins that have key roles in DNA double-strand break repair during the processes of
401:
to attach a membrane anchor to the protein. This version of the protein is also referred to as prelamin A. Farnesylated prelamin A is further
1944:
Al-Haggar M, Madej-Pilarczyk A, Kozlowski L, Bujnicki JM, Yahia S, Abdel-Hadi D, Shams A, Ahmad N, Hamed S, Puzianowska-Kuznicka M (2012).
2534:
Manilal S, Nguyen TM, Sewry CA, Morris GE (1996). "The Emery–Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein".
2079:"Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identity restrictive dermopathy as a lethal neonatal laminopathy" 1141:
production and thus prelamin A farnesylation. Testing of these drugs may prove them to be useful in treating progeria as well. The use of
3598: 354:
such as lamin B receptor and emerin. The nuclear lamina appears to be an adaptation to mobility in animals as sessile organisms such as
4017: 3985: 1660:"Deletion of LBR N-terminal domains recapitulates Pelger-Huet anomaly phenotypes in mouse without disrupting X chromosome inactivation" 520:
of lamin B in cells appears to be crucial for nuclear integrity as increased expression of lamin B causes a degenerative phenotype in
2163: 1148:
to inhibit progerin synthesis in affected cells is another avenue of current research into the development of anti-progerin drugs.
843: 37: 4098: 3720: 3710: 3702: 1610:"Mutations at the mouse ichthyosis locus are within the lamin B receptor gene: a single gene model for human Pelger-Huet anomaly" 1451:"Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger–Huët anomaly)" 560:
syndrome, a dramatic form of premature aging. Mouse cells deficient for maturation of prelamin A show increased DNA damage and
429:
protein emerin appears to be crucial in muscle cells, with certain mutations in lamin mimicking mutations in emerin and causing
1097: 146: 2393:"Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease" 4001: 1391: 773: 748: 723: 430: 323: 3618: 495:
Since the metalloproteinase STE24 is required to process prelamin A into mature lamin A, mutations in this gene abolishing
227:
Laminopathies and other nuclear envelopathies have a large variety of clinical symptoms including skeletal and/or cardiac
3793: 3670: 2654:"Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery–Dreifuss muscular dystrophy" 699: 3166: 3826: 3821: 2742:
Waterham HR, Koster J, Mooyer P, van Noort G, Kelley RI, Wilcox WR, Wanders RJ, Hennekam RC, Oosterwijk JC (2003).
1802:"Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy" 1331:"Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy" 285:
Mutations implicated in other nuclear envelopathies were found in genes coding for lamin-binding proteins such as
4073: 3740: 3630: 1122: 647: 351: 294: 1328: 917:
Lipoatrophy with diabetes, hepatic steatosis, hypertrophic cardiomyopathy, and leukomelanodermic papules (LDHCP)
4048: 3929: 3883: 3715: 3705: 2352:"Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke–Ollendorff syndrome and melorheostosis" 889: 402: 212: 350:
in animal cells. They are attached to the nuclear envelope membrane via farnesyl anchors and interaction with
4093: 3878: 3847: 3798: 3730: 3675: 3645: 3549: 3499: 3469: 3369: 3159: 624: 3052:
Meta M, Yang SH, Bergo MO, Fong LG, Young SG (2006). "Protein farnesyltransferase inhibitors and progeria".
3519: 3453: 3265: 1093: 298: 3135: 4078: 4068: 3339: 3316: 3293: 3255: 3217: 2703:"Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy" 933: 3918: 3899: 3816: 549: 2791:
Muchir A, Bonne G, van der Kooi AJ, van Meegen M, Baas F, Bolhuis PA, de Visser M, Schwartz K (2000).
3980: 3975: 3873: 3697: 3448: 3106: 2649: 2569:
Clements L, Manilal S, Love DR, Morris GE (2000). "Direct interaction between emerin and lamin A".
1060:
Currently, there is no cure for laminopathies and treatment is largely symptomatic and supportive.
1017: 978: 950: 597: 553: 451: 516:
leukodystrophy, the disease is associated with a duplication of the lamin B gene LMNB1. The exact
40:, visualized by immunofluorescence - note the irregular and bumpy shape of the laminopathic nuclei 4012: 3954: 3755: 3559: 3275: 2392: 1006: 77: 319:
mutations creating dominant alleles that do not allow their carriers to reproduce before death.
3665: 3623: 3222: 1138: 1041: 1030: 876: 675: 561: 501: 166: 1717:"Comparative genomics, evolution and origins of the nuclear envelope and nuclear pore complex" 3924: 3412: 3270: 3227: 2194: 2078: 1429: 1372: 1085: 925: 806: 394: 339: 2011: 1283: 1118: 390: 330:
mutation in the EMD gene coding for emerin and affecting an estimated 1 in 100,000 people.
142: 1758:"Role of nuclear lamina-cytoskeleton interactions in the maintenance of cellular strength" 8: 3386: 2000:"Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome" 1800:
Hegele RA, Cao H, Liu DM, Costain GA, Charlton-Menys V, Rodger NW, Durrington PN (2006).
1329:
Hegele RA, Cao H, Liu DM, Costain GA, Charlton-Menys V, Rodger NW, Durrington PN (2006).
819: 471: 138: 90: 66: 2042: 2015: 1999: 1287: 36:
Normal nuclear lamina (a and b) and mutant nuclear lamina (c and d) from a patient with
3893: 3569: 3539: 3509: 3489: 3458: 2993: 2935: 2768: 2743: 2678: 2653: 2630: 2467: 2423: 2332: 2289: 2240: 2215: 2146: 2055: 1970: 1945: 1926: 1826: 1801: 1692: 1538: 1486: 1417: 1355: 1330: 1244: 1217: 1193: 1166: 1065: 900: 785: 760: 735: 533: 513: 434: 228: 70: 57: 2511: 2486: 2320: 1878: 1853: 1306: 1271: 4088: 3634: 3321: 3298: 3250: 3232: 3069: 3034: 2985: 2977: 2927: 2891: 2850: 2814: 2773: 2724: 2683: 2622: 2586: 2551: 2516: 2459: 2415: 2373: 2324: 2281: 2245: 2182: 2138: 2100: 2047: 1975: 1930: 1918: 1883: 1831: 1779: 1738: 1697: 1679: 1639: 1631: 1590: 1582: 1543: 1525: 1478: 1470: 1409: 1360: 1311: 1249: 1198: 425: 406: 380: 121: 82: 50: 45: 3111: 2471: 2427: 2336: 2293: 2150: 1421: 1165:
Paradisi M, McClintock D, Boguslavsky RL, Pedicelli C, Worman HJ, Djabali K (2005).
3861: 3061: 3024: 2997: 2969: 2939: 2919: 2881: 2842: 2804: 2763: 2755: 2714: 2673: 2665: 2634: 2614: 2578: 2543: 2506: 2498: 2451: 2407: 2363: 2316: 2273: 2235: 2227: 2174: 2130: 2090: 2059: 2037: 2027: 2019: 1965: 1957: 1910: 1873: 1865: 1821: 1813: 1769: 1728: 1687: 1671: 1621: 1574: 1533: 1517: 1490: 1462: 1401: 1350: 1342: 1301: 1291: 1239: 1229: 1188: 1178: 1089: 1061: 347: 286: 200: 3745: 3427: 3391: 3364: 3065: 2973: 1774: 1757: 1145: 611: 62: 2411: 2178: 1659: 3942: 3439: 3260: 1675: 1069: 1068:
may be helpful for patients with muscular dystrophies. Laminopathies affecting
904: 686: 572: 343: 305: 248: 208: 3013:"Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors" 4062: 3661: 3191: 2981: 1854:"Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C" 1683: 1635: 1586: 1562: 1529: 1474: 1077: 1073: 993: 965: 634: 398: 386: 309: 232: 158: 134: 86: 1578: 1296: 1234: 532:
Antibodies against lamins are detected in the sera of some individuals with
3182: 3073: 3038: 2989: 2931: 2895: 2854: 2846: 2818: 2809: 2792: 2777: 2728: 2687: 2626: 2590: 2582: 2520: 2463: 2419: 2377: 2328: 2285: 2249: 2231: 2142: 2104: 2075: 2051: 1979: 1922: 1887: 1835: 1783: 1742: 1701: 1643: 1563:"A new autosomal recessive lethal chondrodystrophy with congenital hydrops" 1547: 1482: 1413: 1364: 1315: 1253: 1202: 1183: 1134: 1081: 368: 322:
The nuclear envelopathy with the highest frequency in human populations is
162: 2870:"Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia" 2719: 2702: 2555: 2547: 2186: 1594: 267:
Patients with classical laminopathy have mutations in the gene coding for
189: 4008: 3971: 3937: 3776: 3587: 3435: 3381: 3308: 3200: 2886: 2869: 2095: 2032: 1961: 1943: 1914: 1733: 1716: 1626: 1609: 937: 929: 662: 517: 327: 3098: 2023: 195: 4024: 3641: 3565: 3555: 3545: 3535: 3525: 3515: 3465: 3151: 2647: 2484: 2455: 1130: 1126: 1105: 710: 521: 474:
LMNA mRNA, therefore producing abnormal lamin A protein, also known as
410: 244: 153: 3029: 3012: 1851: 1164: 28: 3949: 3842: 3505: 3495: 3485: 3475: 3443: 3431: 3359: 2349: 1142: 989: 961: 867:
Leukodystrophy, demyelinating, adult-onset, autosomal dominant (ADLD)
830: 658: 240: 173: 1505: 1046:
Lamin A/C or Zinc metalloprotease STE24 (prelamin-processing enzyme)
3869: 3285: 3130: 2759: 2669: 2502: 2368: 2351: 2277: 2134: 1869: 1817: 1521: 1450: 1405: 1346: 854: 607: 557: 496: 467: 455: 414: 279: 252: 236: 204: 2923: 1466: 1272:"Lamin B1 is required for mouse development and nuclear integrity" 450:
Thr528Met/Met540Thr, and Arg471Cys/Arg527Cys, Arg527Leu result in
362:
do not have lamins and the symptoms of many laminopathies include
3992: 3909: 3889: 3785: 3376: 2833:
leukomelanodermic papules, liver steatosis, and cardiomyopathy".
2790: 2618: 2216:"A dual role for A-type lamins in DNA double-strand break repair" 1101: 1656: 1036: 1012: 984: 956: 920: 895: 870: 849: 824: 801: 779: 754: 729: 705: 681: 652: 629: 602: 3808: 3614: 3242: 363: 359: 312: 290: 2440: 2120: 3583: 3579: 3575: 3331: 3209: 2741: 2652:, Bione S, Ricotti R, Schwartz K, Bonne G, Toniolo D (2000). 2603: 1714: 545: 355: 268: 256: 2831: 2213: 1755: 573:
Types of known laminopathies and other nuclear envelopathies
4029: 3761:
Hydrops-ectopic calcification-moth-eaten skeletal dysplasia
479: 376: 372: 297:(LEMD3 gene) and prelamin A-processing enzymes such as the 272: 2952: 1756:
Houben F, Ramaekers FC, Snoeckx LH, Broers JL (May 2007).
798:
Familial partial lipodystrophy of the Dunnigan type (FPLD)
4035:
Microcephalic osteodysplastic primordial dwarfism type II
2568: 1560: 1503: 1270:
Vergnes L, Peterfy M, Bergo MO, Young SG, Reue K (2004).
2908: 2533: 1997: 1448: 1269: 1100:. Treatment for neuropathies may include medication for 556:. Mutations in lamin A (LMNA) cause Hutchinson–Gilford 2390: 2306: 998:
Zinc metalloprotease STE24 (prelamin-processing enzyme)
667:
LEM domain containing protein 3 (lamin-binding protein)
2867: 1900: 1715:
Mans BJ, Anantharaman V, Aravind L, Koonin EV (2004).
1092:
that frequently occur in these patients may require a
478:. The mutations activate a cryptic splice site within 3997:
Epidermolysis bullosa simplex with muscular dystrophy
3088: 2641: 2478: 1799: 3397:Terminal osseous dysplasia with pigmentary defects 420: 3051: 875:Progressive demyelinating disorder affecting the 4060: 2868:Agarwal AK, Fryns JP, Auchus RJ, Garg A (2003). 1216:Chi, YH; Chen, ZJ; Jeang, KT (22 October 2009). 437:forms of muscular dystrophy and cardiomyopathy. 3010: 2262: 1076:requiring treatment with medications including 3530:Meesmann juvenile epithelial corneal dystrophy 3480:Meesmann juvenile epithelial corneal dystrophy 1218:"The nuclear envelopathies and human diseases" 3167: 4018:Arrhythmogenic right ventricular dysplasia 9 3986:Arrhythmogenic right ventricular dysplasia 8 2256: 2207: 2199:: CS1 maint: multiple names: authors list ( 1434:: CS1 maint: multiple names: authors list ( 1377:: CS1 maint: multiple names: authors list ( 1215: 3599:Reticular pigmented anomaly of the flexures 1993: 1991: 1989: 610:with increased severity compared to normal 3174: 3160: 2116: 2114: 2071: 2069: 1847: 1845: 524:and leads to abnormal nuclear morphology. 27: 3028: 2885: 2808: 2767: 2718: 2700: 2677: 2510: 2367: 2343: 2239: 2094: 2041: 2031: 1969: 1877: 1825: 1795: 1793: 1773: 1732: 1691: 1625: 1537: 1354: 1305: 1295: 1265: 1263: 1243: 1233: 1192: 1182: 3594:Naegeli–Franceschetti–Jadassohn syndrome 3181: 2902: 2735: 2562: 2434: 1986: 527: 304:Mutations causing laminopathies include 259:gene) may be lethal before or at birth. 3004: 2861: 2527: 2111: 2066: 1842: 397:into lamins A and C. Lamin A undergoes 4061: 2784: 2384: 1790: 1749: 1607: 1510:The American Journal of Human Genetics 1260: 1158: 507: 389:produced from the LMNA gene undergoes 333: 4084:Medical conditions related to obesity 4002:Epidermolysis bullosa simplex of Ogna 3271:DFN A3, 4, 11, 17, 22; B2, 30, 37, 48 3155: 2597: 490: 222: 3619:Desmin-related myofibrillar myopathy 3256:Hypertrophic cardiomyopathy 1, 8, 10 3045: 2825: 2300: 1708: 1567:American Journal of Medical Genetics 844:Hutchinson–Gilford progeria syndrome 3711:Emery–Dreifuss muscular dystrophy 2 2694: 461: 13: 3976:Striate palmoplantar keratoderma 2 3671:Charcot–Marie–Tooth disease 1F, 2E 3449:Striate palmoplantar keratoderma 3 1209: 881:Lamin B1 (tandem gene duplication) 444: 207:in genes encoding proteins of the 14: 4110: 3827:Asphyxiating thoracic dysplasia 3 3716:Limb-girdle muscular dystrophy 1B 3084: 774:Emery–Dreifuss muscular dystrophy 749:Emery–Dreifuss muscular dystrophy 724:Emery–Dreifuss muscular dystrophy 431:Emery–Dreifuss muscular dystrophy 324:Emery–Dreifuss muscular dystrophy 278:Mutations in the gene coding for 3822:Short rib-polydactyly syndrome 3 3799:Hereditary spastic paraplegia 10 3294:Hypertrophic cardiomyopathy 7, 2 3011:Rusinal AE, Sinensky MS (2006). 981:with type B lipodystrophy (MADB) 953:with type A lipodystrophy (MADA) 3721:Charcot–Marie–Tooth disease 2B1 2946: 2157: 1937: 1894: 1650: 1123:Farnesyl transferase inhibitors 485:tight skin contracture syndrome 483:protein in the neonatal lethal 421:Nonsense and missense mutations 352:inner nuclear membrane proteins 295:LEM domain-containing protein 3 213:inner nuclear membrane proteins 4099:Genetic diseases and disorders 3930:Familial adenomatous polyposis 3884:Hereditary elliptocytosis 2, 3 3794:Charcot–Marie–Tooth disease 2A 3706:Familial partial lipodystrophy 3218:Hypertrophic cardiomyopathy 11 1601: 1554: 1497: 1442: 1385: 1322: 890:Limb-girdle muscular dystrophy 740:Emerin (lamin-binding protein) 1: 3879:Hereditary spherocytosis 2, 3 3848:Cavernous venous malformation 3676:Amyotrophic lateral sclerosis 3646:Amyotrophic lateral sclerosis 3550:Epidermolysis bullosa simplex 3500:Epidermolysis bullosa simplex 3470:Ichthyosis bullosa of Siemens 3340:Hypertrophic cardiomyopathy 9 3317:Hypertrophic cardiomyopathy 3 2571:Biochem. Biophys. Res. Commun 2321:10.1016/S0140-6736(03)14069-X 1222:Journal of Biomedical Science 1151: 776:, autosomal recessive (EDMD3) 539: 3520:Epidermolytic hyperkeratosis 3454:Epidermolytic hyperkeratosis 3066:10.1016/j.molmed.2006.08.006 2974:10.1136/heartjnl-2017-312338 1775:10.1016/j.bbamcr.2006.09.018 1608:Shultz, L. D. (2003-01-01). 1276:Proc. Natl. Acad. Sci. U.S.A 1055: 751:, autosomal dominant (EDMD2) 591: 588: 585: 582: 579: 567: 299:zinc metalloproteinase STE24 7: 3741:Buschke–Ollendorff syndrome 2412:10.1056/NEJM199912023412302 2179:10.7326/0003-4819-108-6-829 1111: 934:hypertrophic cardiomyopathy 700:Charcot–Marie–Tooth disease 648:Buschke–Ollendorff syndrome 262: 10: 4115: 3900:Hereditary spherocytosis 1 3817:Primary ciliary dyskinesia 3223:Dilated cardiomyopathy 1AA 2835:J. Clin. Endocrinol. Metab 1676:10.1038/s42003-021-01944-2 1028: 1004: 976: 948: 915: 887: 865: 841: 817: 796: 771: 746: 721: 697: 678:, with quadriceps myopathy 673: 645: 622: 595: 550:non-homologous end joining 4044: 3964: 3908: 3860: 3835: 3807: 3784: 3775: 3731:Barraquer–Simons syndrome 3684: 3654: 3624:Dilated cardiomyopathy 1I 3607: 3420: 3411: 3370:Weill–Marchesani syndrome 3352: 3330: 3307: 3284: 3241: 3208: 3199: 3190: 3121: 3092: 2701:Cao H, Hegele RA (2002). 1098:implantable defibrillator 625:Barraquer–Simons syndrome 405:into mature lamin A by a 172: 152: 147:implantable defibrillator 130: 126:Clinical, genetic testing 120: 112: 104: 96: 76: 56: 44: 35: 26: 21: 3874:Spinocerebellar ataxia 5 3698:Mandibuloacral dysplasia 3266:Freeman–Sheldon syndrome 2650:Hausmanowa-Petrusewicz I 1614:Human Molecular Genetics 979:Mandibuloacral dysplasia 951:Mandibuloacral dysplasia 598:Atypical Werner syndrome 554:homologous recombination 452:mandibuloacral dysplasia 346:scaffold underneath the 4013:Skin fragility syndrome 3955:Giant axonal neuropathy 3560:Steatocystoma multiplex 1579:10.1002/ajmg.1320290321 1297:10.1073/pnas.0401424101 1235:10.1186/1423-0127-16-96 1086:aldosterone antagonists 903:of hips and shoulders, 676:Cardiomyopathy, dilated 342:proteins that form the 4074:Neurological disorders 3299:Nemaline myopathy 4, 5 2847:10.1210/jc.2002-021506 2583:10.1006/bbrc.1999.2023 2232:10.4161/cc.10.15.16531 1762:Biochim. Biophys. Acta 1664:Communications Biology 1184:10.1186/1471-2121-6-27 1090:abnormal heart rhythms 1031:Restrictive dermopathy 877:central nervous system 562:chromosome aberrations 502:restrictive dermopathy 199:) are a group of rare 167:aldosterone antagonist 4049:Cytoskeletal proteins 2955:"Lamin and the heart" 926:Lipoatrophic diabetes 807:Lipoatrophic diabetes 784:Skeletal and cardiac 759:Skeletal and cardiac 734:Skeletal and cardiac 528:Autoimmune antibodies 413:and its farnesylated 409:removing the last 15 340:intermediate filament 217:nuclear envelopathies 65:, reduced sensation, 4094:Cytoskeletal defects 2810:10.1093/hmg/9.9.1453 1962:10.1038/ejhg.2012.77 1915:10.1002/ajmg.a.32259 1734:10.4161/cc.3.12.1316 1119:farnesyl transferase 391:alternative splicing 3756:Pelger–Huet anomaly 3666:Parkinson's disease 3387:Boomerang dysplasia 3322:Nemaline myopathy 1 3276:May–Hegglin anomaly 3233:Nemaline myopathy 3 2720:10.1093/hmg/9.1.109 2548:10.1093/hmg/5.6.801 2024:10.1038/nature01629 2016:2003Natur.423..293E 1288:2004PNAS..10110428V 1139:farnesyldiphosphate 1007:Pelger–Huet anomaly 820:Greenberg dysplasia 534:autoimmune diseases 508:Gene dosage effects 334:Molecular mechanism 139:orthopaedic surgery 67:shortness of breath 4079:Muscular dystrophy 4069:Muscular disorders 3925:Gardner's syndrome 3894:Long QT syndrome 4 3570:Familial cirrhosis 3540:White sponge nevus 3510:Familial cirrhosis 3490:White sponge nevus 3122:External resources 3023:(Pt 16): 3265–72. 2887:10.1093/hmg/ddg213 2456:10.1002/humu.10170 2096:10.1093/hmg/ddh265 1627:10.1093/hmg/ddg003 1066:orthopedic surgery 1064:and/or corrective 901:Muscular dystrophy 786:muscular dystrophy 761:muscular dystrophy 736:muscular dystrophy 702:, axonal, type 2B1 514:autosomal dominant 491:Processing defects 466:Mutations causing 435:autosomal dominant 426:Missense mutations 229:muscular dystrophy 223:Symptoms and signs 4056: 4055: 3981:Carvajal syndrome 3856: 3855: 3771: 3770: 3635:Alexander disease 3407: 3406: 3348: 3347: 3261:Usher syndrome 1B 3251:Elejalde syndrome 3145: 3144: 3030:10.1242/jcs.03156 2880:(16): 1995–2001. 2748:Am. J. Hum. Genet 2658:Am. J. Hum. Genet 2491:Am. J. Hum. Genet 2129:(10): 1114–1123. 2089:(20): 2493–2503. 1858:Am. J. Hum. Genet 1806:Am. J. Hum. Genet 1400:(10): 1114–1123. 1053: 1052: 726:, X-linked (EDMD) 470:are defective in 407:metalloproteinase 381:connective tissue 301:(ZMPSTE24 gene). 201:genetic disorders 182: 181: 122:Diagnostic method 51:Clinical Genetics 16:Medical condition 4106: 4047:Related topics: 3782: 3781: 3418: 3417: 3206: 3205: 3197: 3196: 3176: 3169: 3162: 3153: 3152: 3090: 3089: 3078: 3077: 3049: 3043: 3042: 3032: 3008: 3002: 3001: 2959: 2950: 2944: 2943: 2906: 2900: 2899: 2889: 2865: 2859: 2858: 2829: 2823: 2822: 2812: 2788: 2782: 2781: 2771: 2739: 2733: 2732: 2722: 2698: 2692: 2691: 2681: 2645: 2639: 2638: 2601: 2595: 2594: 2566: 2560: 2559: 2531: 2525: 2524: 2514: 2482: 2476: 2475: 2438: 2432: 2431: 2397: 2388: 2382: 2381: 2371: 2347: 2341: 2340: 2304: 2298: 2297: 2260: 2254: 2253: 2243: 2211: 2205: 2204: 2198: 2190: 2161: 2155: 2154: 2118: 2109: 2108: 2098: 2073: 2064: 2063: 2045: 2035: 1995: 1984: 1983: 1973: 1941: 1935: 1934: 1909:(8): 1049–1054. 1903:Am J Med Genet A 1898: 1892: 1891: 1881: 1849: 1840: 1839: 1829: 1797: 1788: 1787: 1777: 1753: 1747: 1746: 1736: 1712: 1706: 1705: 1695: 1654: 1648: 1647: 1629: 1605: 1599: 1598: 1558: 1552: 1551: 1541: 1516:(4): 1013–1017. 1501: 1495: 1494: 1446: 1440: 1439: 1433: 1425: 1389: 1383: 1382: 1376: 1368: 1358: 1326: 1320: 1319: 1309: 1299: 1282:(28): 10428–33. 1267: 1258: 1257: 1247: 1237: 1213: 1207: 1206: 1196: 1186: 1162: 1146:oligonucleotides 1062:Physical therapy 1022:Lamin B receptor 892:type 1B (LGMD1B) 835:Lamin B receptor 577: 576: 462:Splicing defects 458:-like features. 348:nuclear envelope 287:lamin B receptor 31: 19: 18: 4114: 4113: 4109: 4108: 4107: 4105: 4104: 4103: 4059: 4058: 4057: 4052: 4040: 3960: 3904: 3852: 3831: 3803: 3767: 3746:Osteopoikilosis 3680: 3650: 3603: 3403: 3392:Larsen syndrome 3365:Marfan syndrome 3344: 3326: 3303: 3280: 3237: 3186: 3180: 3146: 3141: 3140: 3117: 3116: 3101: 3087: 3082: 3081: 3054:Trends Mol. Med 3050: 3046: 3009: 3005: 2957: 2951: 2947: 2912:Nature Genetics 2907: 2903: 2874:Hum. Mol. Genet 2866: 2862: 2830: 2826: 2797:Hum. Mol. Genet 2789: 2785: 2740: 2736: 2707:Hum. Mol. Genet 2699: 2695: 2646: 2642: 2607:Nature Genetics 2602: 2598: 2567: 2563: 2536:Hum. Mol. Genet 2532: 2528: 2483: 2479: 2439: 2435: 2406:(23): 1715–24. 2400:N. Engl. J. Med 2395: 2389: 2385: 2356:Nature Genetics 2348: 2344: 2315:(9382): 440–5. 2305: 2301: 2261: 2257: 2226:(15): 2549–60. 2212: 2208: 2192: 2191: 2162: 2158: 2123:Nature Genetics 2119: 2112: 2083:Hum. Mol. Genet 2074: 2067: 2010:(6937): 293–8. 1996: 1987: 1956:(11): 1134–40. 1950:Eur J Hum Genet 1942: 1938: 1899: 1895: 1850: 1843: 1798: 1791: 1754: 1750: 1727:(12): 1612–37. 1713: 1709: 1655: 1651: 1606: 1602: 1559: 1555: 1502: 1498: 1455:Nature Genetics 1447: 1443: 1427: 1426: 1390: 1386: 1370: 1369: 1327: 1323: 1268: 1261: 1214: 1210: 1163: 1159: 1154: 1114: 1058: 612:Werner syndrome 575: 570: 542: 530: 512:In the case of 510: 493: 464: 447: 445:Point mutations 423: 336: 293:(EMD gene) and 265: 225: 63:Muscle weakness 17: 12: 11: 5: 4112: 4102: 4101: 4096: 4091: 4086: 4081: 4076: 4071: 4054: 4053: 4045: 4042: 4041: 4039: 4038: 4021: 4020: 4015: 4005: 4004: 3999: 3989: 3988: 3983: 3978: 3968: 3966: 3962: 3961: 3959: 3958: 3946: 3943:Naxos syndrome 3934: 3933: 3932: 3927: 3914: 3912: 3906: 3905: 3903: 3902: 3887: 3886: 3881: 3876: 3866: 3864: 3858: 3857: 3854: 3853: 3851: 3850: 3845: 3839: 3837: 3833: 3832: 3830: 3829: 3824: 3819: 3813: 3811: 3805: 3804: 3802: 3801: 3796: 3790: 3788: 3779: 3773: 3772: 3769: 3768: 3766: 3765: 3764: 3763: 3758: 3750: 3749: 3748: 3743: 3735: 3734: 3733: 3725: 3724: 3723: 3718: 3713: 3708: 3700: 3688: 3686: 3682: 3681: 3679: 3678: 3673: 3668: 3658: 3656: 3652: 3651: 3649: 3648: 3638: 3637: 3627: 3626: 3621: 3611: 3609: 3605: 3604: 3602: 3601: 3596: 3591: 3573: 3563: 3553: 3543: 3533: 3523: 3513: 3503: 3493: 3483: 3473: 3463: 3462: 3461: 3456: 3451: 3440:hyperkeratosis 3424: 3422: 3415: 3409: 3408: 3405: 3404: 3402: 3401: 3400: 3399: 3394: 3389: 3384: 3374: 3373: 3372: 3367: 3356: 3354: 3350: 3349: 3346: 3345: 3343: 3342: 3336: 3334: 3328: 3327: 3325: 3324: 3319: 3313: 3311: 3305: 3304: 3302: 3301: 3296: 3290: 3288: 3282: 3281: 3279: 3278: 3273: 3268: 3263: 3258: 3253: 3247: 3245: 3239: 3238: 3236: 3235: 3230: 3225: 3220: 3214: 3212: 3203: 3194: 3192:Microfilaments 3188: 3187: 3179: 3178: 3171: 3164: 3156: 3150: 3149: 3143: 3142: 3139: 3138: 3126: 3125: 3123: 3119: 3118: 3115: 3114: 3102: 3097: 3096: 3094: 3093:Classification 3086: 3085:External links 3083: 3080: 3079: 3044: 3003: 2968:(6): 468–479. 2945: 2901: 2860: 2841:(3): 1006–13. 2824: 2783: 2760:10.1086/373938 2754:(4): 1013–17. 2734: 2693: 2670:10.1086/302869 2664:(4): 1407–12. 2640: 2596: 2561: 2526: 2503:10.1086/339274 2477: 2433: 2383: 2369:10.1038/ng1453 2362:(11): 1213–8. 2342: 2299: 2278:10.1038/nm1266 2255: 2206: 2167:Ann Intern Med 2156: 2135:10.1038/ng1872 2110: 2065: 1985: 1936: 1893: 1870:10.1086/341908 1841: 1818:10.1086/505885 1789: 1748: 1707: 1649: 1600: 1573:(3): 623–632. 1553: 1522:10.1086/373938 1496: 1461:(4): 410–414. 1441: 1406:10.1038/ng1872 1384: 1347:10.1086/505885 1341:(2): 383–389. 1335:Am J Hum Genet 1321: 1259: 1208: 1156: 1155: 1153: 1150: 1113: 1110: 1078:ACE inhibitors 1057: 1054: 1051: 1050: 1047: 1044: 1039: 1034: 1027: 1026: 1023: 1020: 1018:Myelodysplasia 1015: 1010: 1003: 1002: 999: 996: 987: 982: 975: 974: 971: 968: 959: 954: 947: 946: 943: 940: 923: 918: 914: 913: 910: 907: 905:cardiomyopathy 898: 893: 886: 885: 882: 879: 873: 868: 864: 863: 860: 857: 852: 847: 840: 839: 836: 833: 827: 822: 816: 815: 812: 809: 804: 799: 795: 794: 791: 788: 782: 777: 770: 769: 766: 763: 757: 752: 745: 744: 741: 738: 732: 727: 720: 719: 716: 713: 708: 703: 696: 695: 692: 689: 687:Cardiomyopathy 684: 679: 672: 671: 668: 665: 655: 650: 644: 643: 640: 637: 632: 627: 621: 620: 617: 614: 605: 600: 594: 593: 592:Identified in 590: 587: 584: 581: 574: 571: 569: 566: 541: 538: 529: 526: 509: 506: 492: 489: 463: 460: 446: 443: 422: 419: 344:nuclear lamina 335: 332: 264: 261: 249:leukodystrophy 224: 221: 209:nuclear lamina 180: 179: 176: 170: 169: 156: 150: 149: 132: 128: 127: 124: 118: 117: 114: 110: 109: 106: 102: 101: 98: 94: 93: 80: 74: 73: 60: 54: 53: 48: 42: 41: 33: 32: 24: 23: 15: 9: 6: 4: 3: 2: 4111: 4100: 4097: 4095: 4092: 4090: 4087: 4085: 4082: 4080: 4077: 4075: 4072: 4070: 4067: 4066: 4064: 4051: 4050: 4043: 4036: 4032: 4031: 4026: 4023: 4022: 4019: 4016: 4014: 4010: 4007: 4006: 4003: 4000: 3998: 3994: 3991: 3990: 3987: 3984: 3982: 3979: 3977: 3973: 3970: 3969: 3967: 3963: 3956: 3952: 3951: 3947: 3944: 3940: 3939: 3935: 3931: 3928: 3926: 3923: 3922: 3921: 3920: 3916: 3915: 3913: 3911: 3907: 3901: 3898: 3897: 3896: 3895: 3891: 3885: 3882: 3880: 3877: 3875: 3871: 3868: 3867: 3865: 3863: 3859: 3849: 3846: 3844: 3841: 3840: 3838: 3834: 3828: 3825: 3823: 3820: 3818: 3815: 3814: 3812: 3810: 3806: 3800: 3797: 3795: 3792: 3791: 3789: 3787: 3783: 3780: 3778: 3774: 3762: 3759: 3757: 3754: 3753: 3751: 3747: 3744: 3742: 3739: 3738: 3736: 3732: 3729: 3728: 3726: 3722: 3719: 3717: 3714: 3712: 3709: 3707: 3704: 3701: 3699: 3696: 3695: 3693: 3690: 3689: 3687: 3683: 3677: 3674: 3672: 3669: 3667: 3663: 3662:Neurofilament 3660: 3659: 3657: 3653: 3647: 3643: 3640: 3639: 3636: 3632: 3629: 3628: 3625: 3622: 3620: 3616: 3613: 3612: 3610: 3606: 3600: 3597: 3595: 3592: 3589: 3585: 3581: 3577: 3574: 3571: 3567: 3564: 3561: 3557: 3554: 3551: 3547: 3544: 3541: 3537: 3534: 3531: 3527: 3524: 3521: 3517: 3514: 3511: 3507: 3504: 3501: 3497: 3494: 3491: 3487: 3484: 3481: 3477: 3474: 3471: 3467: 3464: 3460: 3457: 3455: 3452: 3450: 3447: 3446: 3445: 3441: 3437: 3433: 3429: 3428:Keratinopathy 3426: 3425: 3423: 3419: 3416: 3414: 3410: 3398: 3395: 3393: 3390: 3388: 3385: 3383: 3382:FG syndrome 2 3380: 3379: 3378: 3375: 3371: 3368: 3366: 3363: 3362: 3361: 3358: 3357: 3355: 3351: 3341: 3338: 3337: 3335: 3333: 3329: 3323: 3320: 3318: 3315: 3314: 3312: 3310: 3306: 3300: 3297: 3295: 3292: 3291: 3289: 3287: 3283: 3277: 3274: 3272: 3269: 3267: 3264: 3262: 3259: 3257: 3254: 3252: 3249: 3248: 3246: 3244: 3240: 3234: 3231: 3229: 3226: 3224: 3221: 3219: 3216: 3215: 3213: 3211: 3207: 3204: 3202: 3198: 3195: 3193: 3189: 3184: 3177: 3172: 3170: 3165: 3163: 3158: 3157: 3154: 3148: 3147: 3137: 3133: 3132: 3128: 3127: 3124: 3120: 3113: 3109: 3108: 3104: 3103: 3100: 3095: 3091: 3075: 3071: 3067: 3063: 3060:(10): 480–7. 3059: 3055: 3048: 3040: 3036: 3031: 3026: 3022: 3018: 3014: 3007: 2999: 2995: 2991: 2987: 2983: 2979: 2975: 2971: 2967: 2963: 2956: 2949: 2941: 2937: 2933: 2929: 2925: 2924:10.1038/ng925 2921: 2917: 2913: 2905: 2897: 2893: 2888: 2883: 2879: 2875: 2871: 2864: 2856: 2852: 2848: 2844: 2840: 2836: 2828: 2820: 2816: 2811: 2806: 2803:(9): 1453–9. 2802: 2798: 2794: 2787: 2779: 2775: 2770: 2765: 2761: 2757: 2753: 2749: 2745: 2738: 2730: 2726: 2721: 2716: 2713:(1): 109–12. 2712: 2708: 2704: 2697: 2689: 2685: 2680: 2675: 2671: 2667: 2663: 2659: 2655: 2651: 2644: 2636: 2632: 2628: 2624: 2620: 2616: 2612: 2608: 2600: 2592: 2588: 2584: 2580: 2577:(3): 709–14. 2576: 2572: 2565: 2557: 2553: 2549: 2545: 2541: 2537: 2530: 2522: 2518: 2513: 2508: 2504: 2500: 2497:(3): 726–36. 2496: 2492: 2488: 2481: 2473: 2469: 2465: 2461: 2457: 2453: 2450:(5): 473–81. 2449: 2445: 2437: 2429: 2425: 2421: 2417: 2413: 2409: 2405: 2401: 2394: 2387: 2379: 2375: 2370: 2365: 2361: 2357: 2353: 2346: 2338: 2334: 2330: 2326: 2322: 2318: 2314: 2310: 2303: 2295: 2291: 2287: 2283: 2279: 2275: 2271: 2267: 2259: 2251: 2247: 2242: 2237: 2233: 2229: 2225: 2221: 2217: 2210: 2202: 2196: 2188: 2184: 2180: 2176: 2172: 2168: 2160: 2152: 2148: 2144: 2140: 2136: 2132: 2128: 2124: 2117: 2115: 2106: 2102: 2097: 2092: 2088: 2084: 2080: 2072: 2070: 2061: 2057: 2053: 2049: 2044: 2039: 2034: 2033:2027.42/62684 2029: 2025: 2021: 2017: 2013: 2009: 2005: 2001: 1994: 1992: 1990: 1981: 1977: 1972: 1967: 1963: 1959: 1955: 1951: 1947: 1940: 1932: 1928: 1924: 1920: 1916: 1912: 1908: 1904: 1897: 1889: 1885: 1880: 1875: 1871: 1867: 1864:(2): 426–31. 1863: 1859: 1855: 1848: 1846: 1837: 1833: 1828: 1823: 1819: 1815: 1811: 1807: 1803: 1796: 1794: 1785: 1781: 1776: 1771: 1768:(5): 675–86. 1767: 1763: 1759: 1752: 1744: 1740: 1735: 1730: 1726: 1722: 1718: 1711: 1703: 1699: 1694: 1689: 1685: 1681: 1677: 1673: 1669: 1665: 1661: 1653: 1645: 1641: 1637: 1633: 1628: 1623: 1619: 1615: 1611: 1604: 1596: 1592: 1588: 1584: 1580: 1576: 1572: 1568: 1564: 1557: 1549: 1545: 1540: 1535: 1531: 1527: 1523: 1519: 1515: 1511: 1507: 1500: 1492: 1488: 1484: 1480: 1476: 1472: 1468: 1467:10.1038/ng925 1464: 1460: 1456: 1452: 1445: 1437: 1431: 1423: 1419: 1415: 1411: 1407: 1403: 1399: 1395: 1388: 1380: 1374: 1366: 1362: 1357: 1352: 1348: 1344: 1340: 1336: 1332: 1325: 1317: 1313: 1308: 1303: 1298: 1293: 1289: 1285: 1281: 1277: 1273: 1266: 1264: 1255: 1251: 1246: 1241: 1236: 1231: 1227: 1223: 1219: 1212: 1204: 1200: 1195: 1190: 1185: 1180: 1176: 1172: 1171:BMC Cell Biol 1168: 1161: 1157: 1149: 1147: 1144: 1140: 1136: 1132: 1128: 1124: 1120: 1109: 1107: 1103: 1099: 1095: 1091: 1087: 1083: 1082:beta blockers 1079: 1075: 1074:heart failure 1071: 1067: 1063: 1048: 1045: 1043: 1040: 1038: 1035: 1032: 1029: 1024: 1021: 1019: 1016: 1014: 1011: 1008: 1005: 1000: 997: 995: 994:lipodystrophy 991: 988: 986: 983: 980: 977: 972: 969: 967: 966:lipodystrophy 963: 960: 958: 955: 952: 949: 944: 941: 939: 935: 931: 927: 924: 922: 919: 916: 911: 908: 906: 902: 899: 897: 894: 891: 888: 883: 880: 878: 874: 872: 869: 866: 861: 858: 856: 853: 851: 848: 845: 842: 837: 834: 832: 828: 826: 823: 821: 818: 813: 810: 808: 805: 803: 800: 797: 792: 789: 787: 783: 781: 778: 775: 772: 767: 764: 762: 758: 756: 753: 750: 747: 742: 739: 737: 733: 731: 728: 725: 722: 717: 714: 712: 709: 707: 704: 701: 698: 693: 690: 688: 685: 683: 680: 677: 674: 669: 666: 664: 660: 656: 654: 651: 649: 646: 641: 638: 636: 635:Lipodystrophy 633: 631: 628: 626: 623: 618: 615: 613: 609: 606: 604: 601: 599: 596: 578: 565: 563: 559: 555: 551: 547: 537: 535: 525: 523: 519: 515: 505: 503: 498: 488: 486: 481: 477: 473: 469: 459: 457: 453: 442: 438: 436: 432: 427: 418: 416: 412: 408: 404: 400: 399:farnesylation 396: 392: 388: 387:Messenger RNA 384: 382: 378: 374: 370: 369:muscle fibers 365: 361: 357: 353: 349: 345: 341: 331: 329: 326:caused by an 325: 320: 318: 314: 311: 307: 302: 300: 296: 292: 288: 283: 281: 276: 274: 270: 260: 258: 254: 250: 246: 242: 238: 234: 233:lipodystrophy 230: 220: 218: 215:are known as 214: 210: 206: 202: 198: 197: 192: 191: 186: 185:Laminopathies 177: 175: 171: 168: 164: 160: 159:ACE inhibitor 157: 155: 151: 148: 144: 140: 136: 135:Physiotherapy 133: 129: 125: 123: 119: 115: 111: 107: 103: 99: 95: 92: 88: 87:heart failure 84: 81: 79: 78:Complications 75: 72: 68: 64: 61: 59: 55: 52: 49: 47: 43: 39: 34: 30: 25: 20: 4046: 4028: 3948: 3936: 3917: 3888: 3777:Microtubules 3691: 3183:Cytoskeletal 3129: 3105: 3057: 3053: 3047: 3020: 3016: 3006: 2965: 2961: 2948: 2918:(4): 410–4. 2915: 2911: 2904: 2877: 2873: 2863: 2838: 2834: 2827: 2800: 2796: 2786: 2751: 2747: 2737: 2710: 2706: 2696: 2661: 2657: 2643: 2619:10.1038/6799 2613:(3): 285–8. 2610: 2606: 2599: 2574: 2570: 2564: 2542:(6): 801–8. 2539: 2535: 2529: 2494: 2490: 2480: 2447: 2443: 2436: 2403: 2399: 2386: 2359: 2355: 2345: 2312: 2308: 2302: 2272:(7): 780–5. 2269: 2265: 2258: 2223: 2219: 2209: 2195:cite journal 2173:(6): 829–3. 2170: 2166: 2159: 2126: 2122: 2086: 2082: 2007: 2003: 1953: 1949: 1939: 1906: 1902: 1896: 1861: 1857: 1812:(2): 383–9. 1809: 1805: 1765: 1761: 1751: 1724: 1720: 1710: 1667: 1663: 1652: 1620:(1): 61–69. 1617: 1613: 1603: 1570: 1566: 1556: 1513: 1509: 1499: 1458: 1454: 1444: 1430:cite journal 1397: 1393: 1387: 1373:cite journal 1338: 1334: 1324: 1279: 1275: 1225: 1221: 1211: 1174: 1170: 1160: 1135:osteoporosis 1115: 1088:, while the 1070:heart muscle 1059: 938:skin lesions 663:skin lesions 589:Mutation in 543: 531: 511: 494: 475: 465: 448: 439: 424: 385: 337: 321: 316: 303: 289:(LBR gene), 284: 277: 266: 243:, dermo- or 226: 216: 194: 188: 184: 183: 163:beta blocker 4009:plakophilin 3972:desmoplakin 3938:plakoglobin 3692:Laminopathy 3588:Monilethrix 3436:keratoderma 3309:Tropomyosin 3201:Myofilament 3017:J. Cell Sci 2910:anomaly)". 930:fatty liver 743:1996, 2000 522:fruit flies 411:amino acids 338:Lamins are 308:as well as 97:Usual onset 91:arrhythmias 22:Laminopathy 4063:Categories 4025:centrosome 3642:Peripherin 3112:D000083083 2444:Hum. Mutat 2220:Cell Cycle 1721:Cell Cycle 1670:(1): 478. 1152:References 1131:tipifarnib 1127:lonafarnib 1106:spasticity 1072:may cause 1042:Dermopathy 711:Neuropathy 540:DNA repair 395:translated 315:with rare 245:neuropathy 203:caused by 154:Medication 3843:Tauopathy 3432:keratosis 3360:Fibrillin 2982:1468-201X 1931:205309256 1684:2399-3642 1636:1460-2083 1587:0148-7299 1530:0002-9297 1475:1061-4036 1394:Nat Genet 1228:(1): 96. 1143:antisense 1094:pacemaker 1056:Treatment 990:Dysplasia 970:Lamin A/C 962:Dysplasia 942:Lamin A/C 909:Lamin A/C 859:Lamin A/C 831:dysplasia 829:Skeletal 811:Lamin A/C 790:Lamin A/C 765:Lamin A/C 715:Lamin A/C 691:Lamin A/C 659:dysplasia 657:Skeletal 616:Lamin A/C 586:Symptoms 580:Syndrome 568:Diagnosis 403:processed 306:recessive 241:dysplasia 205:mutations 174:Prognosis 143:pacemaker 131:Treatment 46:Specialty 4089:Diabetes 3870:Spectrin 3862:Membrane 3703:Dunnigan 3286:Troponin 3131:Orphanet 3074:16942914 3039:16899817 2990:29175975 2932:12118250 2896:12913070 2855:12629077 2819:10814726 2778:12618959 2729:10587585 2688:10739764 2627:10080180 2591:10673356 2521:11799477 2472:32614095 2464:12673789 2428:22942654 2420:10580070 2378:15489854 2337:21980784 2329:12927431 2294:11798376 2286:15980864 2266:Nat. Med 2250:21701264 2151:25336497 2143:16951681 2105:15317753 2052:12714972 2043:10540076 1980:22549407 1923:18348272 1888:12075506 1836:16826530 1784:17050008 1743:15611647 1702:33846535 1644:12490533 1548:12618959 1483:12118250 1422:25336497 1414:16951681 1365:16826530 1316:15232008 1254:19849840 1203:15982412 1112:Research 1102:seizures 1033:, lethal 855:Progeria 639:Lamin B2 608:Progeria 583:OMIM ID 558:progeria 497:protease 476:progerin 472:splicing 468:progeria 456:progeria 415:cysteine 328:X-linked 310:dominant 280:lamin B2 263:Genetics 253:progeria 237:diabetes 178:Variable 108:Lifelong 105:Duration 100:Variable 83:Diabetes 58:Symptoms 3993:plectin 3910:Catenin 3890:Ankyrin 3786:Kinesin 3694:: LMNA 3377:Filamin 3185:defects 2998:3563474 2940:6020153 2769:1180330 2679:1288205 2635:7327176 2556:8776595 2241:3180193 2187:3285745 2060:4420150 2012:Bibcode 1971:3476705 1827:1559499 1693:8041748 1595:3377005 1539:1180330 1491:6020153 1356:1559499 1284:Bibcode 1245:2770040 1194:1183198 1137:reduce 544:A-type 393:and is 317:de novo 313:alleles 275:gene). 190:lamino- 116:Genetic 71:syncope 3809:Dynein 3737:LEMD3 3615:Desmin 3243:Myosin 3228:DFNA20 3072:  3037:  2996:  2988:  2980:  2938:  2930:  2894:  2853:  2817:  2776:  2766:  2727:  2686:  2676:  2633:  2625:  2589:  2554:  2519:  2512:384949 2509:  2470:  2462:  2426:  2418:  2376:  2335:  2327:  2309:Lancet 2292:  2284:  2248:  2238:  2185:  2149:  2141:  2103:  2058:  2050:  2040:  2004:Nature 1978:  1968:  1929:  1921:  1886:  1879:379176 1876:  1834:  1824:  1782:  1741:  1700:  1690:  1682:  1642:  1634:  1593:  1585:  1546:  1536:  1528:  1489:  1481:  1473:  1420:  1412:  1363:  1353:  1314:  1307:478588 1304:  1252:  1242:  1201:  1191:  1177:: 27. 1037:275210 1013:169400 985:608612 957:248370 921:608056 896:159001 871:169500 850:176670 846:(HGPS) 825:215140 802:151660 780:604929 755:181350 730:310300 706:605588 682:607920 653:166700 630:608709 603:277700 546:lamins 518:dosage 364:muscle 356:plants 291:emerin 251:, and 196:-pathy 113:Causes 3965:Other 3836:Other 3727:LMNB 3584:KRT86 3580:KRT83 3576:KRT81 3566:KRT18 3556:KRT17 3546:KRT14 3536:KRT13 3526:KRT12 3516:KRT10 3466:KRT2E 3353:Other 3332:Titin 3210:Actin 3136:98301 2994:S2CID 2962:Heart 2958:(PDF) 2936:S2CID 2631:S2CID 2468:S2CID 2424:S2CID 2396:(PDF) 2333:S2CID 2290:S2CID 2147:S2CID 2056:S2CID 1927:S2CID 1487:S2CID 1418:S2CID 1049:2004 1025:2002 1009:(PHA) 1001:2003 973:2002 945:2003 912:2000 884:2006 862:2003 838:2003 814:2002 793:2000 768:1999 718:2002 694:2003 670:2004 642:2006 619:2003 454:with 360:fungi 271:A/C ( 269:lamin 257:LMNB1 4030:PCNT 3752:LBR 3631:GFAP 3506:KRT8 3496:KRT5 3486:KRT4 3476:KRT3 3459:IHCM 3444:KRT1 3107:MeSH 3070:PMID 3035:PMID 2986:PMID 2978:ISSN 2928:PMID 2892:PMID 2851:PMID 2815:PMID 2774:PMID 2725:PMID 2684:PMID 2623:PMID 2587:PMID 2552:PMID 2517:PMID 2460:PMID 2416:PMID 2374:PMID 2325:PMID 2282:PMID 2246:PMID 2201:link 2183:PMID 2139:PMID 2101:PMID 2048:PMID 1976:PMID 1919:PMID 1907:146A 1884:PMID 1832:PMID 1780:PMID 1766:1773 1739:PMID 1698:PMID 1680:ISSN 1640:PMID 1632:ISSN 1591:PMID 1583:ISSN 1544:PMID 1526:ISSN 1479:PMID 1471:ISSN 1436:link 1410:PMID 1379:link 1361:PMID 1312:PMID 1250:PMID 1199:PMID 1129:and 1104:and 1084:and 992:and 964:and 552:and 480:exon 379:and 377:skin 373:bone 273:LMNA 235:and 38:HGPS 3950:GAN 3919:APC 3442:): 3421:1/2 3062:doi 3025:doi 3021:119 2970:doi 2966:104 2920:doi 2882:doi 2843:doi 2805:doi 2764:PMC 2756:doi 2715:doi 2674:PMC 2666:doi 2615:doi 2579:doi 2575:267 2544:doi 2507:PMC 2499:doi 2452:doi 2408:doi 2404:341 2364:doi 2317:doi 2313:362 2274:doi 2236:PMC 2228:doi 2175:doi 2171:108 2131:doi 2091:doi 2038:PMC 2028:hdl 2020:doi 2008:423 1966:PMC 1958:doi 1911:doi 1874:PMC 1866:doi 1822:PMC 1814:doi 1770:doi 1729:doi 1688:PMC 1672:doi 1622:doi 1575:doi 1534:PMC 1518:doi 1463:doi 1402:doi 1351:PMC 1343:doi 1302:PMC 1292:doi 1280:101 1240:PMC 1230:doi 1189:PMC 1179:doi 1096:or 358:or 4065:: 4027:: 4011:: 3995:: 3974:: 3892:: 3872:: 3664:: 3644:: 3633:: 3617:: 3438:, 3434:, 3413:IF 3134:: 3110:: 3068:. 3058:12 3056:. 3033:. 3019:. 3015:. 2992:. 2984:. 2976:. 2964:. 2960:. 2934:. 2926:. 2916:31 2914:. 2890:. 2878:12 2876:. 2872:. 2849:. 2839:88 2837:. 2813:. 2799:. 2795:. 2772:. 2762:. 2752:72 2750:. 2746:. 2723:. 2709:. 2705:. 2682:. 2672:. 2662:66 2660:. 2656:. 2629:. 2621:. 2611:21 2609:. 2585:. 2573:. 2550:. 2538:. 2515:. 2505:. 2495:70 2493:. 2489:. 2466:. 2458:. 2448:21 2446:. 2422:. 2414:. 2402:. 2398:. 2372:. 2360:36 2358:. 2354:. 2331:. 2323:. 2311:. 2288:. 2280:. 2270:11 2268:. 2244:. 2234:. 2224:10 2222:. 2218:. 2197:}} 2193:{{ 2181:. 2169:. 2145:. 2137:. 2127:38 2125:. 2113:^ 2099:. 2087:13 2085:. 2081:. 2068:^ 2054:. 2046:. 2036:. 2026:. 2018:. 2006:. 2002:. 1988:^ 1974:. 1964:. 1954:20 1952:. 1948:. 1925:. 1917:. 1905:. 1882:. 1872:. 1862:71 1860:. 1856:. 1844:^ 1830:. 1820:. 1810:79 1808:. 1804:. 1792:^ 1778:. 1764:. 1760:. 1737:. 1723:. 1719:. 1696:. 1686:. 1678:. 1666:. 1662:. 1638:. 1630:. 1618:12 1616:. 1612:. 1589:. 1581:. 1571:29 1569:. 1565:. 1542:. 1532:. 1524:. 1514:72 1512:. 1508:. 1485:. 1477:. 1469:. 1459:31 1457:. 1453:. 1432:}} 1428:{{ 1416:. 1408:. 1398:38 1396:. 1375:}} 1371:{{ 1359:. 1349:. 1339:79 1337:. 1333:. 1310:. 1300:. 1290:. 1278:. 1274:. 1262:^ 1248:. 1238:. 1226:16 1224:. 1220:. 1197:. 1187:. 1173:. 1169:. 1121:. 1108:. 1080:, 936:, 932:, 928:, 661:, 536:. 504:. 487:. 383:. 375:, 371:, 247:, 239:, 231:, 219:. 193:+ 165:, 161:, 145:, 141:, 137:, 89:, 85:, 69:, 4037:) 4033:( 3957:) 3953:( 3945:) 3941:( 3685:5 3655:4 3608:3 3590:) 3586:( 3582:/ 3578:/ 3572:) 3568:( 3562:) 3558:( 3552:) 3548:( 3542:) 3538:( 3532:) 3528:( 3522:) 3518:( 3512:) 3508:( 3502:) 3498:( 3492:) 3488:( 3482:) 3478:( 3472:) 3468:( 3430:( 3175:e 3168:t 3161:v 3099:D 3076:. 3064:: 3041:. 3027:: 3000:. 2972:: 2942:. 2922:: 2898:. 2884:: 2857:. 2845:: 2821:. 2807:: 2801:9 2780:. 2758:: 2731:. 2717:: 2711:9 2690:. 2668:: 2637:. 2617:: 2593:. 2581:: 2558:. 2546:: 2540:5 2523:. 2501:: 2474:. 2454:: 2430:. 2410:: 2380:. 2366:: 2339:. 2319:: 2296:. 2276:: 2252:. 2230:: 2203:) 2189:. 2177:: 2153:. 2133:: 2107:. 2093:: 2062:. 2030:: 2022:: 2014:: 1982:. 1960:: 1933:. 1913:: 1890:. 1868:: 1838:. 1816:: 1786:. 1772:: 1745:. 1731:: 1725:3 1704:. 1674:: 1668:4 1646:. 1624:: 1597:. 1577:: 1550:. 1520:: 1493:. 1465:: 1438:) 1424:. 1404:: 1381:) 1367:. 1345:: 1318:. 1294:: 1286:: 1256:. 1232:: 1205:. 1181:: 1175:6 187:(

Index


HGPS
Specialty
Clinical Genetics
Symptoms
Muscle weakness
shortness of breath
syncope
Complications
Diabetes
heart failure
arrhythmias
Diagnostic method
Physiotherapy
orthopaedic surgery
pacemaker
implantable defibrillator
Medication
ACE inhibitor
beta blocker
aldosterone antagonist
Prognosis
lamino-
-pathy
genetic disorders
mutations
nuclear lamina
inner nuclear membrane proteins
muscular dystrophy
lipodystrophy

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑